Literature DB >> 34860194

Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIV.

Samuel S Bailin1, Suman Kundu2, Melissa Wellons3, Matthew S Freiberg2,4, Margaret F Doyle5, Russell P Tracy5, Amy C Justice6,7, Celestine N Wanjalla1, Alan L Landay8, Kaku So-Armah9, Simon Mallal1,10, Jonathan A Kropski4,11, John R Koethe1,4.   

Abstract

OBJECTIVE: A higher proportion of circulating memory CD4+ T cells is associated with prevalent diabetes mellitus in persons with HIV (PWH) and HIV-negative persons. We assessed whether circulating T-cell subsets could also identify individuals who will subsequently develop diabetes.
DESIGN: This is a longitudinal follow-up study of PWH and similar HIV-negative individuals from the Veterans Aging Cohort Study who provided peripheral mononuclear blood cells between 2005 and 2007.
METHODS: We quantified T-cell subsets using flow cytometry and functional assays to identify CD4+ and CD8+ naive, activated, senescent, memory (central, effector, and effector RA+), and TH1, TH2, and TH17-phenotype cells. The occurrence of an incident diabetes diagnosis (i.e. after baseline blood draw) was adjudicated by a two-physician chart review. Cox proportional hazards models adjusted for traditional risk factors, cytomegalovirus serostatus, and plasma inflammatory biomarkers assessed the relationship between T-cell subsets and incident diabetes.
RESULTS: One thousand, eight hundred and thirty-seven participants (1259 PWH) without diabetes at baseline were included; 69% were black, 95% were men, and median follow-up was 8.6 years. Higher baseline frequencies of CD4+ T effector memory RA+ (TEMRA) cells defined as CD45RA+ CD27- (P = 0.04) and senescent T cells defined as CD4+ CD28- (P = 0.04) were associated with incident diabetes in PWH only.
CONCLUSIONS: Higher frequencies of CD4+ TEMRA and CD4+ CD28- T cells were associated with incident diabetes in PWH only after adjustment for other factors. Additional studies are necessary to assess whether these cells act in blood via inflammatory mediators or reflect T-cell populations in metabolically active tissues.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34860194      PMCID: PMC8881388          DOI: 10.1097/QAD.0000000000003137

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  43 in total

1.  The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications.

Authors:  Chun Zeng; Xiaoyun Shi; Baojun Zhang; He Liu; Lianjun Zhang; Wenjun Ding; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2011-10-01       Impact factor: 4.599

2.  The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire.

Authors:  Batoul Pourgheysari; Naeem Khan; Donna Best; Rachel Bruton; Laxman Nayak; Paul A H Moss
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy.

Authors:  Daisuke Takarabe; Yuka Rokukawa; Yoshihiko Takahashi; Atsushi Goto; Maki Takaichi; Masahide Okamoto; Tetsuro Tsujimoto; Hiroshi Noto; Miyako Kishimoto; Yasushi Kaburagi; Kazuki Yasuda; Ritsuko Yamamoto-Honda; Kunihisa Tsukada; Miwako Honda; Katsuji Teruya; Hiroshi Kajio; Yoshimi Kikuchi; Shinichi Oka; Mitsuhiko Noda
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

4.  Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process.

Authors:  Valentina Libri; Rita I Azevedo; Sarah E Jackson; Diletta Di Mitri; Raskit Lachmann; Stephan Fuhrmann; Milica Vukmanovic-Stejic; Kwee Yong; Luca Battistini; Florian Kern; Maria V D Soares; Arne N Akbar
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

5.  Characterization of CD4(+) CTLs ex vivo.

Authors:  Victor Appay; John J Zaunders; Laura Papagno; Julian Sutton; Angel Jaramillo; Anele Waters; Philippa Easterbrook; Pat Grey; Don Smith; Andrew J McMichael; David A Cooper; Sarah L Rowland-Jones; Anthony D Kelleher
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

Review 6.  The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases.

Authors:  Ingrid E Dumitriu
Journal:  Immunology       Date:  2015-09-07       Impact factor: 7.397

7.  Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.

Authors:  Todd T Brown; Katherine Tassiopoulos; Ronald J Bosch; Cecilia Shikuma; Grace A McComsey
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

8.  Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.

Authors:  Nana-Maria Wagner; Gunnar Brandhorst; Frauke Czepluch; Mareike Lankeit; Christoph Eberle; Sebastian Herzberg; Vivien Faustin; Joachim Riggert; Michael Oellerich; Gerd Hasenfuss; Stavros Konstantinides; Katrin Schäfer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

9.  Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study.

Authors:  Alastair D Duncan; Louise M Goff; Barry S Peters
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

10.  Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium.

Authors:  Annette Pachnio; Miriam Ciaurriz; Jusnara Begum; Neeraj Lal; Jianmin Zuo; Andrew Beggs; Paul Moss
Journal:  PLoS Pathog       Date:  2016-09-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.